Mexico’s Ministry of Health and state-owned BIRMEX awarded 673 codes worth MXN 34.4 billion in the third public tender of the 2027–2028 consolidated purchase, bringing coverage to about 90% of required codes. A fourth tender is planned before year-end.

PUBLIC PROCUREMENT · DRUG SUPPLY · NOVEMBER 14, 2026 · MEXICO
Mexico’s Ministry of Health (Secretaría de Salud) and state-owned Laboratorios de Biológicos y Reactivos de México (BIRMEX) have concluded the third public tender of the 2027–2028 Consolidated Purchase of Medicines and Health Supplies, awarding 673 codes (claves) that represent 997.6 million units and an investment of 34.398 billion Mexican pesos (MXN), according to ministry communiqué 309, dated November 3. The results were reported on October 29 by La Jornada and El Universal, citing a joint statement.
With the three tenders completed so far, the ministry said the public sector has close to 90% of the codes it requires for 2027 and 2028, and about 5 billion units awarded in total. The remaining codes will go into a fourth tender planned for this year.
MXN 34.4bn
Value of the 673 codes awarded in the third tender of Mexico’s 2027–2028 consolidated purchase, equal to 997.6 million units, per the Ministry of Health.
What the third tender bought
The tender covered wound-care and other medical consumables (material de curación), laboratory and radiology supplies, medicines and other health supplies, with domestic and international suppliers taking part. Two of every three codes awarded were medical consumables, totaling 791.7 million units, the ministry said. Products of Mexican origin accounted for 57% of the units and 46% of the value awarded.
Of the codes in the procedure, 755 went through the Subsequent Discount Offer (Oferta Subsecuente de Descuento, OSD) mechanism, in which suppliers bid down prices in auctions. The ministry said the mechanism produced a reduction of MXN 7.1 billion; it did not state the baseline used for that calculation, as Consultor Salud noted. The communiqué also does not explain the difference between the 755 codes auctioned and the 673 awarded.
The third round was an open international tender, the format in which the 2025 presidential decree on local production allows extra points for bidders that prove investment in Mexico, according to Mexico Business News, which reported that the tender included 1,196 codes and about 160 suppliers cleared to bid. The ministry’s statement does not say how much the investment points affected the results.
Where the 2027–2028 purchase stands
The first public tender of the cycle, which covered generic, oncology and anti-infective medicines according to El CEO, was reported concluded on September 26, with 3.2 billion units awarded and an investment of close to MXN 84 billion, according to ministry communiqué 262. That communiqué said the purchase of all single-source and patented medicines had concluded on August 3, and that about 15% of codes in that round remained to be contracted through further tenders before the end of 2026.
On November 6, Health Secretary David Kershenobich told the Health and Social Security committees of the Chamber of Deputies that the consolidated purchase totals MXN 353 billion, equivalent to 4,863 million units, and that 92.3% of what the system will need in 2027 and 2028 is secured, according to Notisistema, El Mediático and La Jornada. His 92.3% figure is higher than the communiqué’s “close to 90%” of codes and may use a different base; the sources do not reconcile the two.
From award to delivery
Once rulings are issued, contracts are to be formalized within 20 days, the ministry said. In parallel, the ministry and BIRMEX are working with suppliers to prepare the reception, storage, distribution and dispensing of the awarded products. The government’s consolidated purchase platform lists January 2027 as the start of contracts.
BIRMEX also handles vaccine procurement: in September it directly awarded an open contract for mRNA COVID-19 vaccine to Laboratorios Liomont, as HealthSignals reported.
What to Watch
- The call and rulings for the fourth tender, and how many codes it covers
- Formalization of third-tender contracts within the 20-day window after rulings
- Whether the ministry publishes a single, reconciled figure for codes and units secured for 2027–2028
Why this is relevant
Patients
Awards cover most of the codes public institutions need for 2027–2028, but supply at clinics depends on contract formalization, deliveries and distribution, which the ministry says are still being prepared.
Industry
Suppliers of products in the remaining codes have one more tender this year. Mexican-origin products won 57% of units but 46% of value in the third round.
Payers
The ministry reports MXN 7.1 billion in reductions from discount auctions, without disclosing the baseline used.
Sources: Secretaría de Salud: Communiqué 309, Secretaría de Salud adjudica 997.6 millones de piezas (November 3, 2026) · Secretaría de Salud: Communiqué 262, Concluye licitación de la compra consolidada 2027-2028 · Secretaría de Salud: Compra Consolidada platform · La Jornada: Ssa y Birmex concretan compra de 997.6 millones de piezas · El Universal: Birmex y Salud adjudican 997.6 millones de medicamentos e insumos · Consultor Salud: Compra consolidada de medicamentos 2027-2028 · Mexico Business News: How Plan Mexico local-content points shape medicine tenders · Notisistema: Garantizan la compra de medicamentos para el sector Salud · El Mediático: Sector Salud expone ante Diputados cifras · La Jornada: Gabinete de Salud destaca reducción de mortalidad · El CEO: Birmex podrá acabar con el desabasto de medicamentos
THE HEALTHSIGNALS BRIEF
A fortnightly PDF compiling our analysis on pharma, medical devices, health policy and epidemiology across Latin America and the United States.
Built for pharma, market-access, regulatory, policy and investor teams, with the main findings of our gated reports included.







